For Immediate Release: June 22, 2023 Today, the U.S. Food and Drug Administration approved Elevidys, the first gene therapy for the treatment of pediatric patients 4 through 5 years of age with Duc… [+6814 chars]Read More
FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy FDAgov
